Impact of Definitive Drug–Drug Interaction Testing on Medication Management and Patient Care

BACKGROUND AND OBJECTIVE: Aegis Sciences Corporation developed a test (InterACT Rx(™)) that objectively and definitively identifies substances known to interact with drug–drug interaction-prone medications commonly prescribed in the treatment of chronic pain and behavioral health disorders. The obje...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Renée J. G., Tang, Jun, Schrecker, Joshua, Hild, Cheryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265235/
https://www.ncbi.nlm.nih.gov/pubmed/30298445
http://dx.doi.org/10.1007/s40801-018-0143-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265235/
https://www.ncbi.nlm.nih.gov/pubmed/30298445
http://dx.doi.org/10.1007/s40801-018-0143-z

Ejemplares similares